Laurie Mischley studied naturopathic medicine (ND) at Bastyr University and epidemiology (MPH) and nutritional sciences (PhD) at the University of Washington. Her work is focused on identifying the nutritional requirements unique to individuals with neurodegenerative diseases. She has published on coenzyme Q10, lithium, and glutathione deficiency in Parkinson’s Disease (PD).
As a clinical researcher, Mischley has worked with the FDA, NIH, and the Michael J. Fox Foundation to administer intranasal glutathione, (in)GSH, to individuals with PD. Drawing on expertise in radiology, epidemiology, nutrition, neurology, and naturopathic medicine, she is attempting to determine whether (in)GSH boosts brain glutathione and improves health.
She has served on the Bastyr University Institutional Review Board since 2010 and regularly provides mentorship to students interested in integrative medicine research. She founded the social purpose corporation, NeurRx; developed an outcome measure to assess PD severity; and is author of the book Natural Therapies for Parkinson’s Disease.
Mischley maintains a small clinical practice at Seattle Integrative Medicine focused on nutrition and neurological health.